Xinghan Guo, Wei Wang, Allison Wilde, Yingting Zhu, Guigang Li
{"title":"Reprogramming of Human Limbal Niche Progenitors.","authors":"Xinghan Guo, Wei Wang, Allison Wilde, Yingting Zhu, Guigang Li","doi":"10.7150/ijms.135665","DOIUrl":"10.7150/ijms.135665","url":null,"abstract":"<p><p>Limbal niche cells (LNCs) possess embryonic stem cell (ESC) characteristics, expressing ESC markers such as Sox2, Nanog, and Oct4; stromal characteristics, expressing neurocrest markers such as CD90; and have angiogenic potential expressing angiogenesis markers such as CD34. In addition, these cells can be induced into adipocytes, chondrocytes, and osteocytes, indicating that they are valuable adult stem cells. However, how these cells may be appropriately passaged and maintained, what signaling pathways are necessary for such regeneration, and how the cells can be used for the treatment of various diseases caused by stem cell deficiency, such as limbal stem cell deficiency, remain unclear. Herein, we summarize the most recent advances in limbal niche research, with emphasis on the regeneration of adult limbal progenitors and their mechanisms, to promote cell-based therapy for various eye diseases due to stem cell deficiency or malfunction. Such a strategy may also provide a platform for stem cell therapy for other similar human diseases worldwide.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3440-3452"},"PeriodicalIF":3.7,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149238226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jiun-Hung Geng, Chien-Hsiang Chang, Yi-Chang Liu, Hui-Hua Hsiao, Tsung-Jang Yeh, Jeng-Shiun Du, Min-Hong Wang, Yu-Yin Lin, Wen-Hsin Chang, Chin-Mu Hsu, Chun-Hung Richard Lin, Shih-Feng Cho
{"title":"Associations of Subcutaneous and Visceral Fat Areas with Progression-Free Survival in Patients with Diffuse Large B-Cell Lymphoma.","authors":"Jiun-Hung Geng, Chien-Hsiang Chang, Yi-Chang Liu, Hui-Hua Hsiao, Tsung-Jang Yeh, Jeng-Shiun Du, Min-Hong Wang, Yu-Yin Lin, Wen-Hsin Chang, Chin-Mu Hsu, Chun-Hung Richard Lin, Shih-Feng Cho","doi":"10.7150/ijms.137961","DOIUrl":"https://doi.org/10.7150/ijms.137961","url":null,"abstract":"<p><strong>Background: </strong>Body composition, particularly adipose tissue distribution, may modulate cancer progression and therapeutic outcomes. This study investigated the associations of subcutaneous fat area (SFA) and visceral fat area (VFA) with progression-free survival (PFS) in patients with diffuse large B-cell lymphoma (DLBCL).</p><p><strong>Methods: </strong>This retrospective study included 110 patients with DLBCL diagnosed between 2010 and 2019. SFA and VFA were quantified from baseline computed tomography images using a previously validated automated deep learning-based segmentation system and analyzed as continuous variables standardized to 1-standard deviation (SD) increments. Associations with PFS were evaluated using Cox proportional hazards regression adjusted for the International Prognostic Index (IPI), with joint modeling, sensitivity analyses, restricted cubic spline analysis, and bootstrap internal validation. Overall survival (OS) was additionally evaluated in exploratory analyses.</p><p><strong>Results: </strong>During a mean follow-up of 63.5 ± 45.2 months, 46 PFS events (41.8%) were observed. In separate IPI-adjusted models, each 1-SD increase in SFA was associated with poorer PFS (hazard ratio [HR], 1.34; 95% confidence interval [CI], 1.00-1.79; p = 0.047), whereas VFA was not significantly associated with PFS (HR, 1.09; 95% CI, 0.82-1.44; p = 0.552). In the joint model, the SFA estimate remained similar (HR, 1.33; 95% CI, 0.99-1.79; p = 0.057), whereas the VFA estimate remained close to the null (HR, 1.03; 95% CI, 0.76-1.38; p = 0.868); the standardized coefficients did not differ significantly (p = 0.265). Adding SFA to the IPI yielded a small increase in the apparent C-index (0.618 to 0.632; ΔC-index, 0.014; bootstrap 95% CI, -0.013 to 0.069). In exploratory analyses, neither SFA nor VFA was significantly associated with OS.</p><p><strong>Conclusion: </strong>Higher SFA was associated with poorer PFS after adjustment for the IPI, whereas VFA showed little evidence of an association; however, the difference between their associations was not statistically significant, and neither adipose tissue compartment was significantly associated with OS. The incremental prognostic value of SFA beyond the IPI was limited. Larger studies with external validation are needed to confirm these findings.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3415-3423"},"PeriodicalIF":3.7,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Interaction Between Age and the NOTCH3 p.R544C Variant in Determining Ischemic Stroke Risk: Insights from the Taiwan Biobank Study of 8,588 Patients.","authors":"Yi-Ching Liaw, Oswald Ndi Nfor, Che-Hong Chen, Shu-Yi Hsu, Yi-Chia Liaw, Yung-Po Liaw","doi":"10.7150/ijms.132147","DOIUrl":"https://doi.org/10.7150/ijms.132147","url":null,"abstract":"<p><p>Genetic susceptibility to ischemic stroke may vary across the life course, yet the extent to which aging modifies the effect of specific high-risk variants remains incompletely understood. The <i>NOTCH3</i> rs201118034 (p.R544C) variant, a CADASIL-related mutation with relatively high prevalence in East Asian populations, has been associated with cerebrovascular disease. We investigated whether age modifies the association between the <i>NOTCH3</i> p.R544C variant and ischemic stroke risk at the population level. We integrated data from the Taiwan Biobank (TWB, 2008-2020) with the National Health Insurance Research Database (NHIRD, 2000-2020). Among 112,500 participants, 8,588 ischemic stroke cases were identified. Participants were classified as wild-type (GG) or p.R544C carriers (AG+AA). Logistic regression models were used to estimate stroke risk after adjusting for demographic characteristics, vascular comorbidities, and lifestyle factors. Effect modification by age was evaluated using interaction terms and age-genotype-stratified analyses. Overall, p.R544C carriers exhibited a higher prevalence of ischemic stroke than noncarriers (10.37% vs. 7.61%). The p.R544C variant was associated with higher odds of ischemic stroke (adjusted odds ratio [OR], 1.54; 95% confidence interval [CI], 1.24-1.90). Age was a strong determinant of stroke risk, and a significant interaction between age and genotype was observed (p for interaction = 0.02), indicating that the effect of age on ischemic stroke risk varied by genotype. In the joint age-genotype model, the highest odds of ischemic stroke were observed among AG+AA carriers aged 51-60 years (OR 7.07, 95% CI 5.08-9.82) and 61-70 years (OR 11.40, 95% CI 8.02-16.19), relative to 30-40-year-old GG carriers. These findings indicate that the association between the <i>NOTCH3</i> p.R544C variant and ischemic stroke risk is age-dependent. The progressively stronger genetic effect observed in later adulthood underscores the importance of incorporating age-specific genetic susceptibility into population-based stroke risk stratification and neurogenetic epidemiology.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3424-3431"},"PeriodicalIF":3.7,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685033/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tony Boiadjiev, George Boiadjiev, Ivan Chavdarov, Kamen Delchev, Rumen Kastelov
{"title":"Temperature Increase Limitation During Automatic Bone Drilling in Orthopedic Surgery.","authors":"Tony Boiadjiev, George Boiadjiev, Ivan Chavdarov, Kamen Delchev, Rumen Kastelov","doi":"10.7150/ijms.136882","DOIUrl":"10.7150/ijms.136882","url":null,"abstract":"<p><p>In orthopedic surgery, the most performed manipulation is bone drilling. One significant problem related to this manipulation is the overheating which causes thermal osteonecrosis. By reports the drill speed is the main factor responsible for heat generation and contributes up to 78% to temperature rise during bone drilling. Therefore, the aim of this work is to develop and implement drilling speed control approach to control the temperature rise in drilling area and prevent overheating of bone tissue. During drilling, a real-time drill bit tip temperature estimation is calculated based on data from a non-contact temperature sensor and information from the robot control system. This way, temperature feedback during drilling process is realized. Further, on the base of modified PI controller the target speed depending on the increase in the drill bit tip temperature is calculated. Applying the drill speed control approach, the experimental results showed a decrease in the maximum temperature on the drill bit tip during drilling by up to 13 °C was observed, and the temperature rise was limited to 65-70 °C, with values above 65 °C lasting less than 2 s. The novelty of this work is the realization of temperature feedback and drill speed control approach during drilling process. Applying them in a robotic bone drilling process, the temperature increase in the instrument-bone area was significantly limited, the critical temperature values at which thermal osteonecrosis occurs were not reached, and that substantially reduces the likelihood of thermal osteonecrosis during drilling.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3399-3414"},"PeriodicalIF":3.7,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685032/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149238234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shuying Yan, Jing Zhu, Joaquim M Oliveira, Rui L Reis, Leping Yan, Lin Xiao
{"title":"Reconstructing the Tumor Mechanical Microenvironment in Organoids: From Mechanical Cues to Biomimetic Modeling and Therapeutic Insights.","authors":"Shuying Yan, Jing Zhu, Joaquim M Oliveira, Rui L Reis, Leping Yan, Lin Xiao","doi":"10.7150/ijms.138880","DOIUrl":"10.7150/ijms.138880","url":null,"abstract":"<p><p>The tumor mechanical microenvironment (TMME) is a critical regulator of cancer initiation, progression, metastasis, and therapeutic response. Beyond biochemical signaling, physical cues such as matrix stiffness, solid stress, interstitial fluid flow, and extracellular matrix (ECM) architecture regulate tumor-cell behavior, stromal remodeling, abnormal vascular proliferation and leakage, immune interactions, and drug resistance. However, conventional <i>in vitro</i> and <i>in vivo</i> models remain limited in recapitulating the dynamic, heterogeneous, and coupled mechanical features of native tumors. Tumor organoids, particularly patient-derived tumor organoids (PDOs), have emerged as physiologically relevant and experimentally tractable platforms for modeling tumor mechanics, as they preserve key aspects of tumor architecture, cellular heterogeneity, and genetic background while enabling precise experimental manipulation and high-throughput analysis. This review summarizes recent advances in modeling the TMME in tumor organoids. We first discuss major mechanical features of the tumor microenvironment (TME). We then discuss current strategies for recreating these features in organoid models, including stiffness-defined matrices, engineered ECMs, microfluidic platforms, mechanical actuation systems, multicellular co-culture models, and three-dimensional (3D) bioprinting. We also highlight their applications in mechanistic studies, disease modeling, and drug testing. Finally, we discuss current limitations including the overemphasis on stiffness-based design, limited reproducibility and standardization, and insufficient preservation of tumor spatial heterogeneity and mechanical gradients. We further outline future directions toward controllable, standardized, and patient-specific organoid platforms through advances in engineered matrices, microfluidics, automation, and computational analysis. By shifting from single-parameter modeling to systems-level reconstruction of the TMME, tumor organoid models are becoming increasingly powerful platforms for mechanistic discovery and therapeutic evaluation.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3374-3398"},"PeriodicalIF":3.7,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149238314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"High-Glucose Environment Promotes Radioresistance in Colorectal Cancer via SERPINE1-Enhanced DNA Repair and Anti-Apoptosis.","authors":"Chien-Chih Ke, Yu-Chen Zhang, Po-Jen Wang, Chen-Yu Wang, Shih-Hsun Kuo, Chia-Yang Li, Ming-Yii Huang, Ya-Ju Hsieh","doi":"10.7150/ijms.130794","DOIUrl":"https://doi.org/10.7150/ijms.130794","url":null,"abstract":"<p><strong>Background: </strong>Patients with colorectal cancer (CRC) and comorbid hyperglycemia often exhibit poor responses to preoperative concurrent chemoradiotherapy (CCRT), leading to unfavorable clinical outcomes. However, how hyperglycemia contributes to CRC radioresistance remains incompletely understood. This study aimed to elucidate the molecular mechanisms by which high-glucose exposure promotes radioresistance in CRC.</p><p><strong>Methods: </strong>CRC cell lines (SW480 and HCT116) were cultured under normal-glucose (5 mM), high-glucose (25 mM), or mannitol osmotic control conditions to assess malignant behaviors and radiosensitivity. Relative miRNA expression changes from pooled plasma exosomal miRNA profiling were integrated with TargetScan, miRDB, GeneCards, and TCGA analyses to screen for candidate mediators. Candidate SERPINE1-regulating miRNAs were validated using mimic/inhibitor assays. The functional role of SERPINE1 was validated using siRNA knockdown and plasmid overexpression assays, followed by assays of clonogenic survival, apoptosis, γ-H2AX foci kinetics, and DNA repair-associated protein expression.</p><p><strong>Results: </strong>High-glucose culture significantly enhanced CRC cell proliferation, migration, invasion, epithelial-mesenchymal transition, cancer stemness, and clonogenic radioresistance, whereas mannitol did not reproduce these effects. Integrated exploratory exosomal miRNA and bioinformatic analyses identified SERPINE1 as a candidate mediator associated with hyperglycemia, radioresistance, and poor prognosis. Selected hyperglycemia-associated miRNAs functionally modulated SERPINE1 protein expression in CRC cells. We confirmed that high glucose upregulates SERPINE1 expression <i>in vitro</i>. Mechanistically, SERPINE1 knockdown suppressed malignant phenotypes, reduced stemness-associated traits, enhanced irradiation-induced apoptosis, increased residual γ-H2AX foci, and attenuated DNA repair-associated protein responses. Conversely, SERPINE1 overexpression promoted aggressive phenotypes, reduced apoptotic signaling, accelerated γ-H2AX foci resolution, and enhanced radioresistance.</p><p><strong>Conclusion: </strong>High-glucose exposure promotes CRC malignancy and radioresistance, at least in part, through SERPINE1 upregulation. SERPINE1 contributes to radioresistance by attenuating apoptosis and facilitating radiation-induced DNA damage resolution. These findings support SERPINE1 as a key mechanistic mediator linking high-glucose exposure to radioresistance in CRC cell models. Because the exosomal miRNA profiling was performed using pooled plasma samples, the resulting miRNA findings should be regarded as exploratory and do not constitute a validated biomarker signature. The potential clinical relevance of SERPINE1 requires further validation in independent patient cohorts and physiologically relevant <i>in vivo</i> models.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3356-3373"},"PeriodicalIF":3.7,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Woon-Man Kung, Hsien Chang Yeh, Abel Po-Hao Huang, Md Mohaimenul Islam, Chieh-Chen Wu, Yao-Chin Wang
{"title":"Machine Learning with Social Determinants of Health for Cross-Sectional Diabetes Classification: Development and Temporal Validation.","authors":"Woon-Man Kung, Hsien Chang Yeh, Abel Po-Hao Huang, Md Mohaimenul Islam, Chieh-Chen Wu, Yao-Chin Wang","doi":"10.7150/ijms.137605","DOIUrl":"10.7150/ijms.137605","url":null,"abstract":"<p><strong>Aims: </strong>Our study aimed to determine whether incorporating social determinants of health (SDOH) improves cross-sectional classification of prevalent diagnosed diabetes and to quantify the extent to which model performance is attributable to variables that may occur downstream of diabetes diagnosis.</p><p><strong>Methods: </strong>We analyzed data from the 2023 Behavioral Risk Factor Surveillance System (BRFSS) as the development cohort and the 2024 BRFSS as an independent temporal validation cohort. Analyses were restricted to adults aged 35 years or older residing in states that administered the SDOH module. The outcome was self-reported diagnosed diabetes. Before model development, 30% of the 2023 sample was reserved as a test set. Imputation, encoding, feature processing, and hyperparameter tuning were performed within nested cross-validation. Histogram-based gradient boosting and penalized logistic regression were evaluated across six pre-specified nested predictor specifications. Final models were applied unchanged to the 2024 cohort without refitting, re-tuning, or threshold recalibration. Performance estimates incorporated BRFSS survey weights.</p><p><strong>Results: </strong>The development cohort comprised 179,752 adults (weighted prevalence 16.97%) and the validation cohort 161,092 (18.07%). Discrimination ranged from 0.75 to 0.81 across algorithms, with gradient boosting and penalized logistic regression indistinguishable (0.811 versus 0.808). The full model achieved an area under the receiver operating characteristic curve (AUROC) of 0.811 (95% CI 0.801 - 0.822) and transported to the validation cohort with a calibration slope of 1.040. Adding nine SDOH items changed discrimination by 0.006 (95% CI 0.004 - 0.008), with maximum net benefit gain under 0.003; discrimination rose from 0.743 to 0.811 only when healthcare utilization and comorbidity measures were added. Several SDOH nonetheless showed robust adjusted associations, including food insecurity (OR 1.27 - 1.39) and supplemental nutrition assistance program receipt (OR 1.34, 95% CI 1.11 - 1.61). At a fixed threshold, sensitivity ranged from 0.62 to 0.89 across age groups.</p><p><strong>Conclusions: </strong>SDOH were independently associated with prevalent diagnosed diabetes but provided little incremental value beyond demographic, behavioral, and healthcare access measures, a finding that was consistent across consecutive survey cycles. Most of the observed discrimination was attributable to healthcare utilization and comorbidity variables that may plausibly reflect consequences of an established diagnosis rather than characteristics preceding disease recognition.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3323-3335"},"PeriodicalIF":3.7,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685035/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149238270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xiaokai Wei, Min He, Haili Wang, Xin Xiang, Mengyuan Li, Mengmeng Li, Thanh Tuan Vu Le, Zhongxian Wang, Dingqi Zhang, Lei Cheng, Mengmeng Sun, Hongfeng Wang
{"title":"Metabolomics in the Prediction and Early Diagnosis of Type 2 Diabetes Mellitus: Advances and Applications.","authors":"Xiaokai Wei, Min He, Haili Wang, Xin Xiang, Mengyuan Li, Mengmeng Li, Thanh Tuan Vu Le, Zhongxian Wang, Dingqi Zhang, Lei Cheng, Mengmeng Sun, Hongfeng Wang","doi":"10.7150/ijms.126351","DOIUrl":"10.7150/ijms.126351","url":null,"abstract":"<p><p>Early detection and intervention can prevent the onset and progression of type 2 diabetes mellitus (T2DM); however, achieving early diagnosis and accurate prediction remains challenging. Metabolomics, a potent diagnostic tool in systems biology, makes it possible to systematically identify important biomarkers linked to type 2 diabetes, which provides vital proof for risk assessment and early diagnosis. This review summarizes research advances in metabolomics for T2DM prediction and early detection since 2010 by incorporating both the reported prospective and cross-sectional metabolic evidence, with a focus on putative biomarkers and their metabolic characteristics identified across diverse biological samples. Furthermore, it highlights the unique advantages of metabolomics in T2DM early warning, aiming to offer novel insights for future research on personalized prevention and early diagnostic strategies.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3336-3355"},"PeriodicalIF":3.7,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149238309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy of Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia: A Single-Center Retrospective Study.","authors":"Jinrong Zhao, Liangliang Wu, Ming Zhou, Xiaowei Chen, Wenjian Mo, Ruiqing Zhou, Yumiao Li, Caixia Wang, Shilin Xu, Shiyi Pan, Wei Zhou, Tingfen Deng, Yuping Zhang, Shunqing Wang","doi":"10.7150/ijms.137416","DOIUrl":"https://doi.org/10.7150/ijms.137416","url":null,"abstract":"<p><p>To evaluate the efficacy of unrelated allogeneic hematopoietic stem cell transplantation (URD-HSCT) in severe aplastic anemia (SAA), this study retrospectively analyzed the clinical data of 206 patients at a single center. The median age was 28 years (range: 5-64 years), and 13.6% had received immunosuppressive therapy prior to transplantation. The median time to neutrophil and platelet engraftment was 12 days (range: 9-22 days / 8-55 days), respectively, with a graft failure rate of 3.4%. The cumulative incidence of grade II-IV acute graft-versus-host disease (aGVHD) was 21.7% (95% CI: 16.6%-27.8%), and that of chronic GVHD was 20.4% (95% CI: 15.4%-26.6%). Survival analysis revealed a 7-year overall survival (OS) rate of 91% for the entire cohort. Notably, the 7-year OS rate was significantly higher in the donor age ≤30 years group compared to the >30 years group (97% vs 85%, <i>P</i> = 0.0028), and in the HLA 10/10 matched group compared to the 9/10 matched group (95% vs 86%, <i>P</i> = 0.023). Multivariate analysis identified donor age >30 years, and HLA 9/10 matching as independent risk factors for OS and graft-versus-host disease-free, relapse-free survival (GRFS). URD-HSCT is an effective treatment for SAA, and selecting an appropriate donor can improve treatment outcomes.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3313-3322"},"PeriodicalIF":3.7,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Uğur Ermis, Damla Binentoglu, Erdem Toktay, Huseyin Fatih Gul, Hasan Ilhan, Muhammed Yayla
{"title":"Metformin-Functionalized Selenium Nanoparticles Restore Insulin Signaling and Metabolic Homeostasis in Letrozole-Induced Polycystic Ovary Syndrome Rat Model.","authors":"Uğur Ermis, Damla Binentoglu, Erdem Toktay, Huseyin Fatih Gul, Hasan Ilhan, Muhammed Yayla","doi":"10.7150/ijms.135170","DOIUrl":"10.7150/ijms.135170","url":null,"abstract":"<p><p>In this study, we designed a novel 'metformin-coated nanoselenium nanocomposite' (Met+SeNP) to leverage the synergistic potential of both agents delivered via a single nanoplatform, aiming to restore metabolic and hormonal homeostasis in a letrozole-induced PCOS rat model. Met+SeNP was synthesized via a redox reaction of sodium selenite and ascorbic acid in the presence of metformin, creating a stable metformin-functionalized selenium nanocomposite. The particles were characterized using UV-Vis spectroscopy, SEM, and EDX. Female Sprague-Dawley rats were divided into five groups: Healthy, PCOS (letrozole-induced), Metformin (300 mg/kg), SeNP (0.4 mg/kg), and Met+SeNP (nanocomposite dose, SeNP 0.4 mg/kg + Metformin 300 mg/kg). The nanocomposite treatment most effectively minimized weight gain (39.36% vs. PCOS controls), normalized HOMA-IR, and restored circulating LH, estrogen, and testosterone levels. Histopathological evaluation demonstrated a marked reduction in cystic follicles and recovery of corpus luteum formation following Met+SeNP therapy. Immunohistochemical analysis further revealed that Met+SeNP robustly reversed PCOS-induced suppression of INR, IRS-1, and IRS-2 expression in both liver and skeletal muscle tissues. In addition, the nanocomposite significantly improved serum ALT, AST, and ALP levels while maintaining normal urea and creatinine concentrations, supporting hepatic protection and systemic safety. The metformin-functionalized SeNP nanocomposite represents a promising potent therapeutic strategy for PCOS-associated metabolic dysfunction, outperforming monotherapies in restoring insulin signaling, endocrine balance, and tissue integrity.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 10","pages":"3237-3251"},"PeriodicalIF":3.7,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13617503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149074096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}